Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
01/17/1996 | EP0692541A1 Amplification of midivariant DNA templates |
01/17/1996 | EP0692537A2 Recombinant gibberellin DNA and uses thereof |
01/17/1996 | EP0692535A1 Oligonucleotides to inhibit the role of isoprenyl protein transferases |
01/17/1996 | EP0692488A2 Interleukin 4 signal transducers and binding assays |
01/17/1996 | EP0692031A1 Heterologous antigens in live cell vaccine strains |
01/17/1996 | EP0692029A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
01/17/1996 | EP0692026A1 A human t-cell receptor of the g-protein coupled receptor family |
01/17/1996 | EP0692024A1 AN $g(a)-GALACTOSIDASE ENZYME |
01/17/1996 | EP0691988A1 Inhibitor of stem cell proliferation and uses thereof |
01/17/1996 | EP0691981A1 Tumor targeting with l-enantiomeric oligonucleotide conjugates of immunoreagents and of chelated radionuclides |
01/17/1996 | EP0691979A1 Novel 5'-substituted nucleosides and oligomers produced therefrom |
01/17/1996 | EP0691978A1 Electronically conductive polymer/nucleotide copolymer, preparation method therefor and use thereof |
01/17/1996 | EP0691977A1 Oligonucleotides with amide linkages replacing phosphodiester linkages |
01/17/1996 | EP0691948A1 Protecting group for use in oligodeoxyribonucleotide synthesis |
01/17/1996 | EP0691853A1 ANTISENSE OLIGOS WHICH INTERFERE WITH mRNA CAP ACTIVITY AND INHIBIT TRANSLATION |
01/17/1996 | EP0691828A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage |
01/17/1996 | EP0667919A4 Improved electrochemiluminescent label for dna probe assays. |
01/17/1996 | EP0618924A4 Hbv amplifier probes for use in solution phase sandwich hybridization assays. |
01/17/1996 | CN1030718C Superoxide dismutase |
01/16/1996 | US5484909 Nucleic acid probes for the detection of bacteria of the genera Pediococcus and Lactobacillus and methods for the detection of the bacterial agents causing spoilage of beer |
01/16/1996 | US5484908 Uracil or cytosine derivatives, detection of dna sequences |
01/16/1996 | US5484891 Pure polypeptide able to hybridize under low stringency conditions; glycoproteins |
01/16/1996 | US5484724 DNA encoding GLSI |
01/16/1996 | US5484711 DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI |
01/11/1996 | WO1996000583A1 Polynucleotide vaccine for papillomavirus |
01/11/1996 | WO1996000575A1 Polynucleoside chain having multiple nucleosides, the nucleosides coupled by guanidyl linkages |
01/11/1996 | DE4424307A1 Simultaneous, multiple solid phase synthesis of peptide(s), other bio-organic polymers, or libraries of them |
01/11/1996 | DE4424263A1 New 3'-derivatised oligo:nucleotide analogues |
01/11/1996 | DE4422259A1 Anti-Sinn-Oligonukleotide zur Aromatase-Inhibierung Antisense oligonucleotides for aromatase inhibition |
01/10/1996 | EP0691406A1 Process for the preparation of superoxide dismutase by recombinant DNA-technology |
01/10/1996 | EP0691402A2 Modified satellite-RNA's and satellite-viruses as support for adapted ribozymes |
01/10/1996 | EP0690990A1 Parvovirus receptors and methods of use |
01/10/1996 | EP0690929A1 NUCLEIC ACID PROBES FOR THE DETECTION OF $i(HAEMOPHILUS INFLUENZAE) |
01/10/1996 | EP0690928A1 Nucleotide esters for use in nucleic acid sequencing |
01/10/1996 | EP0690914A1 Allergenic protein and peptides from house dust mite and uses therefor |
01/10/1996 | EP0690873A1 Growth differentiation factor-8 |
01/10/1996 | EP0690726A1 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells |
01/10/1996 | EP0690716A1 OLIGONUCLEOTIDES MODIFIED TO IMPROVE STABILITY AT ACID pH |
01/10/1996 | EP0690675A1 Nucleic acid coding for a tumor rejection antigen precursor |
01/10/1996 | EP0690673A1 Systemic gene treatment of connective tissue diseases |
01/10/1996 | EP0620822A4 Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system. |
01/10/1996 | EP0594837B1 Radiolabelled compound formulations |
01/10/1996 | EP0529088B1 NOVEL PLASMID pBUL1 DERIVED FROM LACTOBACILLUS AND DERIVATIVE THEREOF |
01/09/1996 | US5482850 Method for identifying anti-parasitic compounds |
01/04/1996 | WO1996000297A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-1 AND 2 |
01/04/1996 | WO1996000242A1 Retinoic acid receptor epsilon |
01/04/1996 | WO1996000231A1 Anti-sense oligonucleotides for aromatase inhibition |
01/04/1996 | WO1996000229A1 Novel oligosaccharide derivatives, preparation method therefor and uses thereof |
01/04/1996 | WO1996000007A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
01/04/1996 | WO1996000006A1 Inducible nitric oxide synthase gene for treatment of disease |
01/04/1996 | WO1995033059A3 Receptor for oncostatin m |
01/04/1996 | WO1995025806A3 Packaging-deficient lentiviruses |
01/04/1996 | CA2193827A1 Inducible nitric oxide synthase gene for treatment of disease |
01/03/1996 | EP0690129A1 Novel entities for cancer therapy |
01/03/1996 | EP0690127A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
01/03/1996 | EP0689610A1 Dna sequencing by mass spectrometry via exonuclease degradation |
01/03/1996 | EP0689609A1 Process for typing hla-b using specific primers and probes sets |
01/03/1996 | EP0689599A1 Chimeric selectin by exchange of domains - uses thereof |
01/03/1996 | EP0689597A1 USE OF PORCINE GAL $g(a)(1,3) GALACTOSYL TRANSFERASE IN XENOGRAFT THERAPIES |
01/03/1996 | EP0689593A1 Inhibition of selected tumor growth with recombinant viral sector |
01/03/1996 | EP0689592A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
01/03/1996 | EP0689590A1 Totally synthetic affinity reagents |
01/03/1996 | EP0689588A1 Extracellular signal-regulated kinase, sequences, and methods of production and use |
01/03/1996 | EP0689551A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
01/03/1996 | EP0689547A1 Cloned human alpha1c adrenergic receptor |
01/03/1996 | EP0689460A1 Cyclobutyl antisense oligonucleotides, methods of making and use thereof |
01/03/1996 | EP0689433A1 Novel metal binding agents, and methods and compositions for their use to treat metal toxicity |
01/03/1996 | EP0689430A1 Superparamagnetic particles, process for producing the same and their use |
01/02/1996 | US5480972 Diagnosing, treating and preventing sensitivity; dna sequences |
01/02/1996 | US5480864 Modified maxadilan fusion protein containing a thrombin cleavage site; composition for topical application to mammals' skin comprises modified maxadilan protein as vasodilator in vehicle |
01/02/1996 | US5480801 Purified PH neutral Rhizoctonia laccases and nucleic acids encoding same |
01/02/1996 | US5480799 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
12/30/1995 | CA2152233A1 Oligonucleotides to inhibit the expression of isoprenyl protein transferases |
12/28/1995 | WO1995035503A1 Synthesis of combinatorial libraries |
12/28/1995 | WO1995035380A1 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
12/28/1995 | WO1995035118A1 Contraceptive vaccine |
12/28/1995 | WO1995035102A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
12/28/1995 | WO1995020664A3 Mammalian expression systems for hepatitis c virus envelope genes |
12/28/1995 | CA2193206A1 Contraceptive vaccine |
12/28/1995 | CA2193064A1 Synthesis of combinatorial libraries |
12/28/1995 | CA2192950A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
12/27/1995 | EP0688873A2 Fast DNA assay for the detection of chinolon resistant staphylococcus aureus in clinical material |
12/27/1995 | EP0688784A2 3'-Modified oligonucleotide derivatives |
12/27/1995 | EP0688366A1 Sensitive nucleic acid sandwich hybridization assays and kits |
12/27/1995 | EP0688362A1 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
12/27/1995 | EP0688360A1 Bone stimulating factor |
12/27/1995 | EP0402402B1 Inhibition of htlv-iii by exogenous oligonucleotides |
12/27/1995 | CN1113916A Extracting method for ribonucleic acid (RNA) |
12/26/1995 | US5478893 End-attachment of oligonucleotides to polyacrylamide solid supports for capture and detection of nucleic acids |
12/24/1995 | CA2152426A1 Crucifer aft proteins and uses thereof |
12/24/1995 | CA2152218A1 Rapid dna test for detecting quinolone-resistant staphylococcus aureus pathogens in clinical material |
12/21/1995 | WO1995034654A1 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator |
12/21/1995 | WO1995034651A2 Corticotropin-releasing factor2 receptors |
12/21/1995 | WO1995034578A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
12/21/1995 | WO1995034569A1 Universal process for isolating and purifying nucleic acids from extremely small amounts of highly contaminated various starting materials |
12/21/1995 | WO1995033048A3 P2x receptors (purinoceptor family) |
12/21/1995 | WO1995027066A3 Dna encoding ubiquitin conjugating enzymes |
12/21/1995 | WO1995020660A3 Immunization by inoculation of dna transcription unit |
12/21/1995 | DE4420737A1 New 3'-derivatised oligo:nucleotide analogues |
12/21/1995 | CA2193072A1 Corticotropin-releasing factor2 receptors |